Q4 2025 Earnings Call March 30, 2026 4:30 PM EDTCompany ParticipantsDaniel Carlson - Head of Investor RelationsDavid Moss ...

Company to Host Conference Call Today, March 30, at 4:30pm ETBOCA RATON, Fla., March 30, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company ...

Realizing the benefits of regenerative medicine will require a structural shift toward earlier detection and therapeutic intervention.

Discover how a new method for measuring iron flux helps scientists to rapidly identify high-quality cells for use in ...

Boca Raton, Florida, March 24, 2026 (GLOBE NEWSWIRE)-- INmune Bio Inc. (NASDAQ: INMB) (the "Company”), a clinical-stage inflammation and immunology company, today announced that it will host a ...

Mesoblast (ASX:MSB) founder and CEO Prof Silviu Itescu has a markedly more relaxed demeanor than in the past, when investors ...

Researchers have developed a new method for monitoring iron flux - the movement and rate at which cells take in, store, use ...

Spinal cord injury (SCI) often leads to long-term loss of motor and sensory function, with limited available treatment options to restore the lost ...

Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Department of Medicine, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City US Department ...

CytoNiche’s 3D FloTrix™ platform won the Emerging Bioprocessing Supplier – Downstream award at ABEA 2026, recognising ...

Detailed price information for Mesoblast Ltd Ord (MEOBF) from The Globe and Mail including charting and trades.